Alexza Pharmaceuticals Inc
ALXA
ALXA was delisted on the 16th of June, 2016.
40 hedge funds and large institutions have $30M invested in Alexza Pharmaceuticals Inc in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 6 closing their positions.
2,535% more call options, than puts
Call options by funds: $5.53M | Put options by funds: $210K
50% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 10
1% more capital invested
Capital invested by funds: $29.6M → $30M (+$348K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 45 → 40 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$393K |
| 2 |
LPA
Lansdowne Partners Austria
Vienna,
Austria
|
+$306K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$211K |
| 4 |
FAM
Fortaleza Asset Management
Chicago,
Illinois
|
+$156K |
| 5 |
Goldman Sachs
New York
|
+$125K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.02M |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$202K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$183K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$172K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$135K |
ALXA Hedge Fund Activity: Q2 2014 in Review
40 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q2 2014, worth a combined $30M — up 1.2% from $29.6M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ALXA and 1 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 15 added.
The largest buyer was Morgan Stanley, adding an estimated $393K. The largest seller was Kennedy Capital Management, cutting an estimated $1.02M.
- 40 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q2 2014, down from 45 in Q1 2014.
- Funds reported $30M of Alexza Pharmaceuticals Inc stock for Q2 2014, up 1.2% quarter-over-quarter.
- 1 fund opened new Alexza Pharmaceuticals Inc positions in Q2 2014 and 6 closed out, a net change of -5 holders.
- The largest Alexza Pharmaceuticals Inc buyer in Q2 2014 was Morgan Stanley, an estimated $393K added.
- The largest Alexza Pharmaceuticals Inc seller in Q2 2014 was Kennedy Capital Management, an estimated $1.02M sold.
Based on aggregated 13F filings for Q2 2014.